IRWD logo

Ironwood Pharmaceuticals (IRWD) Cash From Financing

Annual CFF

$277.16 M
+$514.71 M+216.67%

December 31, 2023

Summary

Performance

1-Year Change

+216.67%

3-Year Change

+1394.45%

5-Year Change

+821.65%

15-Year Change

+1297.33%

IRWD Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

95.04%
IRWD annual cash flow from financing activities is higher than 95.04% of companies in Healthcare sector

High & Low

All-time High

$313.58 M
IRWD annual cash flow from financing activities is currently -11.61% below its historical high of $313.58 million

3-Year Low

-$237.55 M

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
IRWD previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Feb 21, 2025
IRWD next annual earnings announcement is scheduled for Feb 21, 2025

OtherIRWDcash flowmetrics:

Annual CFI

-$1.03 B
IRWD annual cash flow from investing activities is -$1.03 billion

Annual CFO

$183.43 M
IRWD annual cash flow from operations is $183.43 million

Annual FCF

$183.15 M
IRWD annual free cash flow is $183.15 million

Annual CAPEX

$273.00 K
IRWD annual capital expenditures is $273.00 thousand

Quarterly CFF

-$27.16 M
+$22.22 M+45.00%

September 30, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

0%

3-Year Change

-46.1%

5-Year Change

-46.1%

IRWD Quarterly CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

8.41%
IRWD quarterly cash flow from financing activities is higher than 8.41% of companies in Healthcare sector

High & Low

All-time High

$399.07 M
IRWD quarterly cash flow from financing activities is currently -106.80% below its historical high of $399.07 million

3-Year Low

-$150.28 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
IRWD previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 21, 2025
IRWD next earnings announcement is scheduled for Feb 21, 2025

OtherIRWDcash flowmetrics:

Quarterly CFI

-$16.00 K
IRWD quarterly cash flow from investing activities is -$16.00 thousand

Quarterly CFO

$9.88 M
IRWD quarterly cash flow from operations is $9.88 million

Quarterly FCF

$9.87 M
IRWD quarterly free cash flow is $9.87 million

Quarterly CAPEX

$16.00 K
IRWD quarterly capital expenditures is $16.00 thousand

TTM CFF

-$142.99 M
+$47.83 M+25.07%

September 30, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

0%

3-Year Change

-3042.57%

5-Year Change

-3042.57%

IRWD TTM CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

8.23%
IRWD TTM cash flow from financing activities is higher than 8.23% of companies in Healthcare sector

High & Low

All-time High

$406.65 M
IRWD TTM cash flow from financing activities is currently -135.16% below its historical high of $406.65 million

3-Year Low

-$258.95 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
IRWD previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 21, 2025
IRWD next earnings announcement is scheduled for Feb 21, 2025

OtherIRWDcash flowmetrics:

TTM CFI

-$4.33 M
IRWD TTM cash flow from investing activities is -$4.33 million

TTM CFO

$124.17 M
IRWD TTM cash flow from operations is $124.17 million

TTM FCF

$123.82 M
IRWD TTM free cash flow is $123.82 million

TTM CAPEX

$353.00 K
IRWD TTM capital expenditures is $353.00 thousand

Cash From Financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

IRWD Cash From Financing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+216.7%0.0%0.0%
3 y3 years+1394.5%-46.1%-3042.6%
5 y5 years+821.6%-46.1%-3042.6%

IRWD Cash From Financing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+216.7%-106.8%+81.9%-135.2%+44.8%
5 y5-yearat high+216.7%-106.8%+81.9%-135.2%+44.8%
alltimeall time-11.6%+216.7%-106.8%+81.9%-135.2%+44.8%

Ironwood Pharmaceuticals Cash From Financing History

DateAnnualQuarterlyTTM
Sep 2024
-
-$27.16 M(-45.0%)
-$142.99 M(-25.1%)
Jun 2024
-
-$49.37 M(+217.4%)
-$190.82 M(-174.1%)
Mar 2024
-
-$15.55 M(-69.4%)
$257.62 M(-7.0%)
Dec 2023
$277.16 M(-216.7%)
-$50.90 M(-32.1%)
$277.16 M(-16.2%)
Sep 2023
-
-$74.99 M(-118.8%)
$330.87 M(-18.6%)
Jun 2023
-
$399.07 M(>+9900.0%)
$406.65 M(-385.0%)
Mar 2023
-
$3.98 M(+41.9%)
-$142.70 M(-39.9%)
Dec 2022
-$237.55 M(+5120.9%)
$2.81 M(+252.1%)
-$237.55 M(-8.3%)
Sep 2022
-
$797.00 K(-100.5%)
-$258.95 M(+2.1%)
Jun 2022
-
-$150.28 M(+65.4%)
-$253.58 M(+159.7%)
Mar 2022
-
-$90.87 M(+388.9%)
-$97.63 M(+2045.8%)
Dec 2021
-$4.55 M(-124.5%)
-$18.59 M(-401.5%)
-$4.55 M(-125.9%)
Sep 2021
-
$6.16 M(+8.9%)
$17.56 M(+45.5%)
Jun 2021
-
$5.66 M(+156.1%)
$12.07 M(+37.1%)
Mar 2021
-
$2.21 M(-37.3%)
$8.80 M(-52.5%)
Dec 2020
$18.55 M(-1665.1%)
$3.52 M(+426.0%)
$18.55 M(-13.6%)
Sep 2020
-
$670.00 K(-72.0%)
$21.47 M(-27.1%)
Jun 2020
-
$2.40 M(-79.9%)
$29.43 M(+50.7%)
Mar 2020
-
$11.96 M(+85.4%)
$19.54 M(-1748.5%)
Dec 2019
-$1.19 M(-103.9%)
$6.45 M(-25.3%)
-$1.19 M(-57.4%)
Sep 2019
-
$8.63 M(-215.1%)
-$2.78 M(-22.8%)
Jun 2019
-
-$7.50 M(-14.4%)
-$3.61 M(-122.5%)
Mar 2019
-
-$8.77 M(-280.8%)
$16.02 M(-46.7%)
Dec 2018
$30.07 M(+51.6%)
$4.85 M(-37.9%)
$30.07 M(-4.2%)
Sep 2018
-
$7.81 M(-35.6%)
$31.39 M(+262.1%)
Jun 2018
-
$12.13 M(+129.5%)
$8.67 M(+44.0%)
Mar 2018
-
$5.29 M(-14.2%)
$6.02 M(-69.7%)
Dec 2017
$19.84 M(-575.0%)
$6.16 M(-141.3%)
$19.84 M(+5.2%)
Sep 2017
-
-$14.91 M(-257.3%)
$18.85 M(-37.9%)
Jun 2017
-
$9.48 M(-50.4%)
$30.37 M(+61.6%)
Mar 2017
-
$19.10 M(+269.0%)
$18.80 M(-550.1%)
Dec 2016
-$4.18 M
$5.18 M(-252.8%)
-$4.18 M(-64.3%)
DateAnnualQuarterlyTTM
Sep 2016
-
-$3.39 M(+61.8%)
-$11.70 M(-4.8%)
Jun 2016
-
-$2.09 M(-45.9%)
-$12.28 M(-104.2%)
Mar 2016
-
-$3.87 M(+65.1%)
$293.78 M(-3.1%)
Dec 2015
$303.07 M(+43.7%)
-$2.34 M(-41.0%)
$303.07 M(-3.1%)
Sep 2015
-
-$3.98 M(-101.3%)
$312.92 M(-2.0%)
Jun 2015
-
$303.97 M(+5510.4%)
$319.37 M(+1328.5%)
Mar 2015
-
$5.42 M(-27.8%)
$22.36 M(-89.4%)
Dec 2014
$210.94 M(-32.7%)
$7.50 M(+203.1%)
$210.94 M(+3.1%)
Sep 2014
-
$2.48 M(-64.5%)
$204.64 M(+0.7%)
Jun 2014
-
$6.96 M(-96.4%)
$203.13 M(-39.8%)
Mar 2014
-
$194.00 M(>+9900.0%)
$337.28 M(+7.6%)
Dec 2013
$313.58 M(+252.4%)
$1.20 M(+23.6%)
$313.58 M(+0.0%)
Sep 2013
-
$967.00 K(-99.3%)
$313.45 M(+0.2%)
Jun 2013
-
$141.12 M(-17.1%)
$312.95 M(+80.7%)
Mar 2013
-
$170.30 M(>+9900.0%)
$173.17 M(+94.6%)
Dec 2012
$88.97 M(+2739.9%)
$1.07 M(+127.5%)
$88.97 M(+0.5%)
Sep 2012
-
$469.00 K(-64.8%)
$88.53 M(-0.1%)
Jun 2012
-
$1.33 M(-98.5%)
$88.62 M(-0.0%)
Mar 2012
-
$86.10 M(>+9900.0%)
$88.64 M(+2729.2%)
Dec 2011
$3.13 M(-98.5%)
$620.00 K(+9.7%)
$3.13 M(-3.7%)
Sep 2011
-
$565.00 K(-58.1%)
$3.25 M(+54.3%)
Jun 2011
-
$1.35 M(+125.2%)
$2.11 M(+372.9%)
Mar 2011
-
$599.00 K(-19.3%)
$446.00 K(-99.8%)
Dec 2010
$202.96 M(+387.1%)
$742.00 K(-227.7%)
$202.96 M(-6.5%)
Sep 2010
-
-$581.00 K(+85.0%)
$217.05 M(-10.5%)
Jun 2010
-
-$314.00 K(-100.2%)
$242.54 M(-0.0%)
Mar 2010
-
$203.11 M(+1269.4%)
$242.65 M(+482.4%)
Dec 2009
$41.66 M(-14.2%)
$14.83 M(-40.5%)
$41.66 M(+55.3%)
Sep 2009
-
$24.92 M(<-9900.0%)
$26.83 M(+1301.8%)
Jun 2009
-
-$209.00 K(-109.8%)
$1.91 M(-9.8%)
Mar 2009
-
$2.12 M
$2.12 M
Dec 2008
$48.56 M(-4.2%)
-
-
Dec 2007
$50.72 M
-
-

FAQ

  • What is Ironwood Pharmaceuticals annual cash flow from financing activities?
  • What is the all time high annual CFF for Ironwood Pharmaceuticals?
  • What is Ironwood Pharmaceuticals annual CFF year-on-year change?
  • What is Ironwood Pharmaceuticals quarterly cash flow from financing activities?
  • What is the all time high quarterly CFF for Ironwood Pharmaceuticals?
  • What is Ironwood Pharmaceuticals quarterly CFF year-on-year change?
  • What is Ironwood Pharmaceuticals TTM cash flow from financing activities?
  • What is the all time high TTM CFF for Ironwood Pharmaceuticals?
  • What is Ironwood Pharmaceuticals TTM CFF year-on-year change?

What is Ironwood Pharmaceuticals annual cash flow from financing activities?

The current annual CFF of IRWD is $277.16 M

What is the all time high annual CFF for Ironwood Pharmaceuticals?

Ironwood Pharmaceuticals all-time high annual cash flow from financing activities is $313.58 M

What is Ironwood Pharmaceuticals annual CFF year-on-year change?

Over the past year, IRWD annual cash flow from financing activities has changed by +$514.71 M (+216.67%)

What is Ironwood Pharmaceuticals quarterly cash flow from financing activities?

The current quarterly CFF of IRWD is -$27.16 M

What is the all time high quarterly CFF for Ironwood Pharmaceuticals?

Ironwood Pharmaceuticals all-time high quarterly cash flow from financing activities is $399.07 M

What is Ironwood Pharmaceuticals quarterly CFF year-on-year change?

Over the past year, IRWD quarterly cash flow from financing activities has changed by $0.00 (0.00%)

What is Ironwood Pharmaceuticals TTM cash flow from financing activities?

The current TTM CFF of IRWD is -$142.99 M

What is the all time high TTM CFF for Ironwood Pharmaceuticals?

Ironwood Pharmaceuticals all-time high TTM cash flow from financing activities is $406.65 M

What is Ironwood Pharmaceuticals TTM CFF year-on-year change?

Over the past year, IRWD TTM cash flow from financing activities has changed by $0.00 (0.00%)